Back to search
FDAFDA · Food and drugs·Recall number D-0552-2026

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Published June 10, 2026 · Recall initiated: May 18, 2026

Summary

FDA records drug Class III recall D-0552-2026, published June 10, 2026 and initiated May 18, 2026. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 168,300 vials; Lot: Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

What to do

Voluntary: Firm initiated · Letter

Get an email if LIDOLOG KIT has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LIDOLOG KIT
Manufacturer
Eugia US LLC
Distributor
US Nationwide.
Lot
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02 recalled?

Yes. FDA published recall D-0552-2026 on June 10, 2026. Reported hazard: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LIDOLOG KIT.